Navigation Links
First adhere, then detach and glide forward
Date:12/23/2009

How do one-celled parasites move from the salivary gland of a mosquito through a person's skin into red blood cells? What molecular mechanisms form the basis for this very important movement of the protozoa? A team of researchers headed by Dr. Friedrich Frischknecht, head of a research group at the Department of Infectious Diseases at Heidelberg University Hospital, observed the initial stage of the malaria parasite that is transmitted by mosquitoes with new microscope techniques. They discovered that the parasite continually alternates between phases of rapid gliding and phases of firm adhesion to the surface. The interaction of these two processes probably enables the parasite to move rapidly over a long time, which is necessary for successful transmission of the disease. The research was a colaboration within the CellNetworks cluster of excellence and published in the prestigious journal Cell Host & Microbe.

The CellNetworks cluster of excellence

Researchers from three different disciplines at the CellNetworks cluster of excellence were involved in the study. This is one of the first studies ever in which modern biophysical methods were used to examine parasites. Leading this study were, in addition to Dr. Friedrich Frischknecht of the Parasitology Department, Professor Dr. Ulrich Schwarz from the Institute of Theoretical Physics and Professor Dr. Joachim Spatz from the Institute of Biophysical Chemistry at the University of Heidelberg.

The goal of the CellNetworks cluster of excellence is to describe and understand complex biological networks. It consists of numerous scientific institutions in the Mannheim/Heidelberg region and was founded at the University of Heidelberg in 2006 as part of the excellence initiative of the Deutsche Forschungsgemeinschaft (German Research Foundation) as one of the first excellence institutions in Germany.

How does the motility mechanism of the malaria parasite function?

Malaria is caused by plasmodia, tiny parasites that enter the human body through the saliva of a mosquito when it bites. They use active movements to enter into the bloodstream and from there to cells of the liver and finally into blood cells. A Plasmodium parasite consists of a single cell that has small motors (myosin) in its inner cell wall that are connected to the outer cell wall by movable elements (actin). Certain protein structures (TRAP, thrombospondin-related anonymous protein) are located there, with which the protozoa can adhere to the surface. The components of this motility mechanism that is essential for the parasite are known to a great extent, but the spatial and temporal dynamics of the individual components are still unclear.

The "stick-slip" method

Under special microscopes, the researchers observed how the sporozoites adhere to several sites on the surface via the TRAP protein and then use the short actin filaments to push their body past these adhesion points. "The parasite can stretch forward while still attaching with its rear end thus building up elastic energy. At the moment when the rear adhesion is detached, energy is released and the sporozoite glides forward rapidly," explains Dr. Friedrich Frischknecht. The researchers call this mechanism the "stick-slip" method. The speed of movement is regulated by the formation and turnover of adhesion sites, the existence and dynamics of which have been described for the first time.


'/>"/>

Contact: Dr. Friedrich Frischknecht
freddy.frischknecht@med.uni-heidelberg.de
49-622-156-6537
University Hospital Heidelberg
Source:Eurekalert  

Related biology news :

1. Which came first, the moth or the cactus?
2. First all-African GM crop is resistant to maize streak virus
3. Scientists retrace evolution with first atomic structure of an ancient protein
4. CU-Boulder team discovers first ancient manioc fields in Americas
5. First finding of a metabolite in 1 sex only
6. First orchid fossil puts showy blooms at some 80 million years old
7. First individual genome sequence published
8. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
9. UNH becomes first university in nation to use landfill gas as primary energy source
10. Scientists in first global study of poison gas in the atmosphere
11. Weight gain between first and second pregnancies associated with increased odds of male second child
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First adhere, then detach and glide forward
(Date:12/7/2016)... , Dec. 7, 2016   Avanade is ... Formula One teams in history, exploit biometric data in ... performance and maintain the competitive edge against their rivals ... Avanade has worked with Williams during ... of biometric data (heart rate, breathing rate, temperature and ...
(Date:12/5/2016)... , Dec. 5, 2016  The Office of ... published "Can CT Scans Enhance or Replace Medico ... potential of supporting or replacing forensic autopsies with ... scan. In response to recommendations made ... exploring using CT scans as a potential component ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, ... that discovers, develops and plans to commercialize innovative ... shares of common stock were approved for trading ... begin trading on the OTCQX, effective today, under ... for the OTCQX market, companies must meet high ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. ... and expansion clinical trial for its lead drug candidate, AC0010, at the World ... trial was to determine the safety, antitumor activity, and recommended phase II dosage ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or ... will be presented at the Company,s Annual and Special Meeting. ... Shareholders will take place on Thursday, December 15, 2016 at ... Hall (Room EC1040), 4825 Mount Royal Gate SW, ... A notice of meeting and management information circular, containing the ...
Breaking Biology Technology: